Veterinary Diagnostics Market Trends, Size & Companies 2024-2032

IMARC Group's report titled "Veterinary Diagnostics Market Report by Product (Instruments, Kits and Reagents, Software and Services), Technology (Immunodiagnostics, Clinical Biochemistry, Molecular Diagnostics, Hematology, and Others), Animal Type (Companion Animals, Livestock Animals), Disease Type (Infectious Diseases, Non-infectious Diseases, Hereditary, Congenital and Acquired Diseases, General Ailments, Structural and Functional Diseases), End User (Reference Laboratories, Veterinary Hospitals and Clinics, and Others), and Region 2024-2032". The global veterinary diagnostics market size reached US$ 6.6 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 12.6 Billion by 2032, exhibiting a growth rate (CAGR) of 7.3% during 2024-2032.

For an in-depth analysis, you can refer sample copy of the report: https://www.imarcgroup.com/veterinary-diagnostics-market/requestsample

Factors Affecting the Growth of the Veterinary Diagnostics Industry:

• Increasing Prevalence of Zoonotic Diseases:

The rising occurrence of zoonotic diseases, which are infections transmitted from animals to humans, is contributing to the market growth. These diseases, such as Lyme disease, rabies, and brucellosis, pose public health risks, emphasizing the need for accurate and timely diagnosis to prevent outbreaks. The growing awareness among pet parents and livestock producers about the importance of animal health and its direct impact on human health is driving the demand for veterinary diagnostic services and products. Governing agencies and health organizations are investing in surveillance and control measures to manage zoonotic diseases. The development of advanced diagnostic technologies, including molecular diagnostics and point-of-care testing, is improving the detection and monitoring of these diseases.

• Technological Advancements in Diagnostic Methods:

Innovations like clustered, regularly interspaced short palindromic repeats (CRISPR)-based diagnostics, next-generation sequencing, and advanced imaging technologies are improving veterinary medicine by enhancing the accuracy, efficiency, and range of diagnostic tests available. These advancements enable early detection of diseases, personalized treatment plans, and better management of animal health, leading to higher demand for sophisticated diagnostic solutions. The integration of artificial intelligence (AI) and machine learning (ML) in diagnostic processes is further improving the precision and speed of analysis, facilitating rapid decision-making in clinical settings.

• Livestock Production and Health Management:

The rising demand for animal protein and the need to ensure the health and productivity of livestock, including cattle, swine, poultry, and sheep, is contributing to the market growth. Effective disease management and prevention are critical for maintaining the sustainability and profitability of livestock production. Diagnostic testing plays an essential role in identifying and controlling infectious diseases, improving herd health management, and enhancing biosecurity measures. The implementation of regular health monitoring and disease surveillance programs is further catalyzing the demand for veterinary diagnostics. This is supported by government regulations and policies aimed at preventing disease outbreaks and ensuring food safety.

Leading Companies Operating in the Global Veterinary Diagnostics Industry:

• BioChek B.V.

• Biomérieux SA

• Heska Corporation

• IDvet

• IDEXX Laboratories Inc.

• Neogen Corporation

• Randox Laboratories Ltd.

• Thermo Fisher Scientific Inc.

• Virbac

• Zoetis Inc.

Veterinary Diagnostics Market Report Segmentation:

By Product:

• Instruments

• Kits and Reagents

• Software and Services

Kits and reagents exhibit a clear dominance in the market attributed to their widespread use in a variety of tests, offering quick, reliable results for numerous animal diseases.

By Technology:

• Immunodiagnostics

• Clinical Biochemistry

• Molecular Diagnostics

• Hematology

• Others

Clinical biochemistry represents the largest segment, as it provides essential information on the metabolic and physiological status of animals.

By Animal Type:

• Companion Animals

  • Dogs

  • Cats

  • Others

• Livestock Animals

  • Cattle

  • Swine

  • Poultry

  • Others

Livestock animals hold the biggest market share accredited to the rising need for disease prevention and efficient production in livestock farming to ensure food security and economic stability.

By Disease Type:

• Infectious Diseases

• Non-infectious Diseases

• Hereditary, Congenital and Acquired Diseases

• General Ailments

• Structural and Functional Diseases

Non-infectious diseases account for the majority of the market share, driven by the growing concern over chronic conditions and genetic disorders in animals that impact longevity and quality of life.

By End User:

• Reference Laboratories

• Veterinary Hospitals and Clinics

• Others

Reference laboratories represent the largest segment due to their advanced diagnostic capabilities, comprehensive test offerings, and the expertise to handle a wide range of samples from various animal species.

Regional Insights:

• North America: (United States, Canada)

• Asia Pacific: (China, Japan, India, South Korea, Australia, Indonesia, Others)

• Europe: (Germany, France, United Kingdom, Italy, Spain, Russia, Others)

• Latin America: (Brazil, Mexico, Others)

• Middle East and Africa

North America dominates the market owing to the existence of robust animal healthcare infrastructure, the increasing number of pet parents, and the rising investment in animal health research and development (R&D).

Global Veterinary Diagnostics Market Trends:

The growing integration of digital health technologies and telemedicine services is creating new opportunities for veterinary practices to offer remote consultations, diagnostics, and monitoring services, thereby expanding their reach and improving access to veterinary care, especially in underserved or remote areas. The adoption of digital platforms and mobile applications for managing patient data, scheduling appointments, and facilitating direct communication between veterinarians and pet parents is enhancing the efficiency and convenience of veterinary services.

Additionally, wearable devices for animals, equipped with sensors to monitor vital signs and detect health issues in real time, are becoming popular. These devices generate a vast amount of data, which, when analyzed with advanced analytics, can provide insights into animal health trends, predict outbreaks of diseases, and personalize health care recommendations.

Note: If you need specific information that is not currently within the scope of the report, we will provide it to you as a part of the customization.

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARCs information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the companys expertise.

Our offerings include comprehensive market intelligence in the form of research reports, production cost reports, feasibility studies, and consulting services. Our team, which includes experienced researchers and analysts from various industries, is dedicated to providing high-quality data and insights to our clientele, ranging from small and medium businesses to Fortune 1000 corporations.

Contact Us:

IMARC Group

134 N 4th St. Brooklyn, NY 11249, USA

Email: sales@imarcgroup.com

Tel No:(D) +91 120 433 0800

United States: +1-631-791-1145